ATP, a global leader in life sciences venture capital, is developing the next generation of transformative biotechnology companies. ATP creates science-based companies starting with assets at various stages: from working with scientists on pre-IP ideas, to spinouts from existing company pipelines. The firm provides flexible capital, strategic
insight, and operational resources to build sustainable, research-driven enterprises. ATP invests in its portfolio companies from seed stage through IPO and beyond and supports their management teams in strategic transactions and synergistic business combinations.
Website:www.appletreepartners.com
Industries:
Biopharma
Biotechnology
Genetics
Health Care
Life Science
Therapeutics
Medical
Investor Types:
Venture Capital
Investment Stages:
Late Stage Venture
Early Stage Venture
Location:
New York City, New York, United States
Contact information:
